LEXINGTON, Massachusetts, April 25, 2017 /PRNewswire/ --
Shire plc (LSE: SHP, NASDAQ: SHPG) announces that
Jeff Poulton, Chief Financial Officer, will participate at the Deutsche Bank 42nd annual health care conference, at the InterContinental Boston Hotel on Thursday, May 4, 2017 at 10:40
A live audio webcast will be available on the Presentations and Webcasts section of Shire's Investor website at http://investors.shire.com/presentations-and-webcasts/. Subsequently, a replay of the webcast will be available on this same website for approximately 90 days.
NOTES TO EDITORS
Shire is the leading global biotechnology company focused on serving people with rare diseases and other highly specialized conditions. We strive to develop best-in-class products, many of which are available in more than 100 countries, across core therapeutic areas including Hematology, Immunology, Neuroscience, Ophthalmics, Lysosomal Storage Disorders, Gastrointestinal / Internal Medicine / Endocrine and Hereditary Angioedema; and a growing franchise in Oncology.
Our employees come to work every day with a shared mission: to develop and deliver breakthrough therapies for the hundreds of millions of people in the world affected by rare diseases and other high-need conditions, and who lack effective therapies to live their lives to the fullest.
For further information please contact:
Investor Relations Ian Karp firstname.lastname@example.org +1-781-482-9018
Robert Coates email@example.com +44-1256-894874
SOURCE Shire plc
Subscribe to our Free Newsletters!
Age related macular degeneration is a disease of the elderly, wherein the macula or the central ...
It is time to enjoy the cool weather with the advent of the rains. Along with fun, one should also ...
Learn the basics about diabetes and how to bring it under control with turmeric, an highly ...View All